Prostate Cancer Research Is Group Effort
by William J. Catalona, M.D.

"I would like to keep our donors informed about the progress of our productive, multi-institutional research group that is recognized by our scientific peers."
William J. Catalona, MD

Projects in scientific research are not done by one person anymore.

Often, they are a team effort involving scientists from all parts of the United States and other countries as well.

The collaborative research groups on prostate cancer coordinated by Dr. Catalona are supported by donations to the Urological Research Foundation.

The following is a list of selected recent publications from members of Dr. Catalona’s collaborative research group supported in part by the URF.

Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Benerjee TK, Goddard KAB, Witte JS, Elston RC, Catalona WJ:
A genome screen of multiplex prostate cancer sibships.
American Journal Human Genetics 66: 933-944, 2000.

Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, Catalona WJ, Milbrandt J:
Tissue factor expression and angiogenesis in human prostate carcinoma.
Human Pathology 31: 443-447, 2000.

Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ:
Genomewide scan for prostate cancer-aggressiveness loci.
American Journal of Human Genetics 67: 92-99, 2000.

Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G:
Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.
Cancer Research 60: 3645-3649, 2000.

Suarez BK, Lin J, Witte JS, Conti DV, Resnick MI, Klein EA, Burmester JK, Vaske DA, Banerjee TK, Catalona WJ:
Replication linkage study for prostate cancer susceptibility genes.
Prostate: 45: 106-114, 2000.

Abdulkadir SA, Qu ZC, Garabedian E, Song SK, Peters TJ, Svaren J, Carbone JM, Naughton CK, Catalona WJ, Ackerman JJH, Gordon JI, Humphrey PA, Milbrandt J:
Impaired prostate tumorigenesis in Egr1-deficient mice.
Nature Medicine 7:101-107, 2001.

Verhage Bas AJ, Baffoe-Bonnie AB, Baglietto L, Smith DSS, Bailey-Wilson JE, Beaty TH, Catalona WJ, Kiemeney LA:
Autosomal dominant inheritance of prostate cancer: a confirmatory study.
Urology 57: 97-101, 2001.

Naughton M, Picus J, Zhu X, Catalona WJ, Vollmer RT, Humphrey PA:
Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer.
Journal of Urology 165: 1325-1328, 2001.

Goddard KAB, Witte JS, Suarez BK, Catalona WJ, Olson JM:
Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.
American Journal of Human Genetics 68: 1197-1206, 2001.

Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA, Milbrandt J:
Expression profiling reveals hepsin overexpression in prostate cancer.
Cancer Research (in press) 2001.

Suarez BK, Gerhard DS, Lin J, Haberer B, Nguyen L, Kesterson NK, Catalona WJ:
Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.
Cancer Research (in press) 2001.

Reding DJ, Zhang KQ, Salzman SA, Thomalla JV, Riepe RE, Suarez BK, Catalona WJ, Burmester JK:
Identification of a gene frequently mutated in prostate tumors.
Medical Oncology (in press) 2001.